Inventor
IGNATOVICH OLGA
GB20 patents
⚠️ This page may combine multiple inventors who share the name “IGNATOVICH OLGA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
9 patentsUS9228018B2Jan 5, 2016
Antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO11 citations91
US8895010B2Nov 25, 2014
Antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO24 citations91
US10919965B2Feb 16, 2021
Compositions monovalent for CD28 binding and methods of use
BRISTOL MYERS SQUIBB CO3 citations83
US9908937B2Mar 6, 2018
Compositions monovalent for CD28 binding and methods of use
BRISTOL MYERS SQUIBB CO5 citations83
US9765150B2Sep 19, 2017
Antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO5 citations82
US8981072B2Mar 17, 2015
Nucleic acids encoding antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO8 citations82
US10196451B2Feb 5, 2019
Methods of treating immune diseases by administering antibody polypeptides that specifically bind CD40L
BRISTOL MYERS SQUIBB CO1 citations71
US12012452B2Jun 18, 2024
Compositions monovalent for CD28 binding and methods of use
BRISTOL MYERS SQUIBB CO0 citations61
US11180567B2Nov 23, 2021
Antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO0 citations61
AGENUS INC
7 patentsUS11242385B2Feb 8, 2022
Anti-CD137 antibodies and methods of use thereof
AGENUS INC8 citations84
US11692042B2Jul 4, 2023
Anti-CD73 antibodies and methods of use thereof
AGENUS INC3 citations69
US12492393B2Dec 9, 2025
Anti-CD137 antibodies and methods of use thereof
AGENUS INC0 citations61
US11098117B2Aug 24, 2021
Anti-CD137 antibodies and methods of use thereof
AGENUS INC0 citations61
US11680098B2Jun 20, 2023
Antibodies that specifically bind human CD96
AGENUS INC1 citations54
US12479913B2Nov 25, 2025
Polynucleotide encoding anti-TIGIT and anti-CD96 antibodies
AGENUS INC0 citations53
US11718669B2Aug 8, 2023
Anti-TIGIT and anti-CD96 antibodies
AGENUS INC0 citations53
MCKINNON MURRAY
3 patentsUS9085629B2Jul 21, 2015
Compositions monovalent for CD28 binding and methods of use
MCKINNON MURRAY18 citations90
US8454959B2Jun 4, 2013
Compositions monovalent for CD28 binding and methods of use
MCKINNON MURRAY23 citations90
US8168759B2May 1, 2012
Compositions monovalent for CD28 binding and methods of use
MCKINNON MURRAY21 citations90